Across the United States, a wave of state‑level oversight bills is curbing the rapid expansion of private‑equity firms into the health‑care sector. According to a recent PitchBook report, the number of private‑equity‑involved health‑care transactions has fallen since last year, and the total dollar value of those deals in the first half of 2026 is already lower than the same period in 2025.
State legislation drives the slowdown
PitchBook analysts point to a growing chorus of state laws as a primary factor. At least 25 states have introduced or enacted statutes that increase scrutiny of health‑care mergers, acquisitions and other financial transactions. The new rules often restrict the ability of companies that are not physician‑run to control medical practices, and they demand greater documentation and transparency.
California, Oregon and Rhode Island each implemented new regulations this year that require detailed reporting on health‑care deals. Rhode Island Attorney General Peter Neronha, a Democrat, warned that unchecked private‑equity consolidation drives up the cost of care and threatens patient access. He said the new oversight will give his office a “bird’s‑eye view” to protect Rhode Islanders from harmful mergers.
Impact on physician‑practice management firms
The sector feeling the greatest pressure is physician‑practice management – companies that handle scheduling, billing and other administrative tasks for doctors. Private‑equity has long dominated this niche, but the report projects a 50% decline in deals this year compared with 2025.
Seven states – California, Indiana, Massachusetts, Maine, New Mexico, Oregon and Washington – passed legislation last year that erected guardrails around private‑equity involvement in health‑care. Other states, including Connecticut, Hawaii, Indiana, New York, Pennsylvania, Vermont and Virginia, have introduced bills that would further limit how private‑equity firms operate in the sector.
Why the crackdown?
Public outrage over hospital closures, nursing‑home crises, patient abuse and neglect has intensified scrutiny of private‑equity ownership. Critics argue that profit‑driven consolidation raises costs and reduces access to care. A 2023 study found that private‑equity ownership increased nursing‑home death rates by 11%, while other research linked such ownership to higher emergency‑room visits and rising Medicare expenses. Moody’s Investors Service reported that nearly 90% of financially stressed health‑care companies are owned by private‑equity firms.
Proponents of private‑equity contend that their capital helps hospitals and physicians upgrade technology and streamline operations. However, the data cited by PitchBook suggests that the regulatory push is already reshaping the market, making transactions slower, more costly and less attractive to investors.
Looking ahead
While Congress has not yet passed federal legislation addressing private‑equity health‑care deals, state lawmakers appear poised to continue tightening oversight. The trend signals a shift toward greater transparency and protection for patients, families and health‑care workers – a development that aligns with the values of responsible stewardship and community well‑being.
Stakeholders in the health‑care industry, from physicians to investors, will need to adapt to a landscape where state regulators play a more active role in safeguarding access to affordable, high‑quality care.
Original reporting: The Connecticut Mirror — read the source article.
